Altimmune Inc (NASDAQ:ALT) has a beta value of 0.58 and has seen 0.93 million shares traded in the recent trading session. The company, currently valued at $429.46M, closed the recent trade at $5.30 per share which meant it lost -$0.13 on the day or -2.49% during that session. The ALT stock price is -110.57% off its 52-week high price of $11.16 and 33.02% above the 52-week low of $3.55. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.02 million shares traded. The 3-month trading volume is 2.53 million shares.
The consensus among analysts is that Altimmune Inc (ALT) is Buy stock at the moment, with a recommendation rating of 1.20. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 6 have rated it as a Hold, with 6 advising it as a Buy. 0 have rated the stock as Underweight.
Altimmune Inc (NASDAQ:ALT) trade information
Over the past 30 days, the shares of Altimmune Inc (NASDAQ:ALT) have changed 2.42%. Short interest in the company has seen 22.67 million shares shorted with days to cover at 10.19.
Wall Street analysts have a consensus price target for the stock at $25, which means that the shares’ value could jump 78.8% from the levels at last check today.. The projected low price target is $12.0 while the price target rests at a high of $35.0. In that case, then, we find that the latest price level in today’s session is -560.38% off the targeted high while a plunge would see the stock gain -126.42% from the levels at last check today..
Altimmune Inc (ALT) estimates and forecasts
The company’s shares have lost -37.19% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 3.48% over the past 5 years. Earnings growth for 2025 is a modest 6.95% while over the next 5 years, the company’s earnings are expected to increase by 2.31%.
ALT Dividends
Altimmune Inc is expected to release its next earnings report on 2025-May-12 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Altimmune Inc (NASDAQ:ALT)’s Major holders
Insiders own 0.76% of the company shares, while shares held by institutions stand at 47.87% with a share float percentage of 48.24%. Investors are also buoyed by the number of investors in a company, with Altimmune Inc having a total of 243.0 institutions that hold shares in the company. The top two institutional holders are BLACKROCK INC. with over 5.32 million shares worth more than $35.39 million. As of 2024-06-30, BLACKROCK INC. held 7.5025% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 4.91 million shares as of 2024-06-30. The firm’s total holdings are worth over $32.63 million and represent 6.9181% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . As of Mar 31, 2025 , the former fund manager holds about 2.76% shares in the company for having 2.24 shares of worth $11.88 million while later fund manager owns 1.93 shares of worth $10.25 million as of Mar 31, 2025 , which makes it owner of about 2.38% of company’s outstanding stock.
